What is the price target for Ambu?
Equity research coverage for Ambuja Cements Limited features a consensus 12-month average price target averaging around 655.00 Indian rupees per share, with bull-case targets scaling up to 840.00 Indian rupees. Institutional forecasts reflect structural tailwinds in India's construction sector, capacity expansion initiatives through strategic acquisitions, robust volume growth, and anticipated earnings per share compounding monitored across industrial equity markets.
Related FAQs
Ambu specializes in the design, development, and manufacture of innovative single-use medical devices for hospitals, clinics, and emergency medical services worldwide.
The share price of Ambu A/S (traded on NASDAQ OMX Copenhagen under the symbol AMBU-B) is approximately 73.50 DKK.
Assessing Ambu A/S as an equity investment involves analyzing secular growth trends in single-use medical devices, hospital infection control priorities, and international market penetration.
Ambu A/S, a leading Danish medical device manufacturer, trades on the Copenhagen Stock Exchange under the ticker AMBU-B with a share price around 73.50 DKK.
Ambu A/S is an authentic, publicly traded corporate entity listed on Nasdaq Copenhagen, where its shares are actively bought and sold by institutional investment funds, mutual funds, and retail shareholders.
Ambu A/S is widely recognized as a premier, highly reputable global medical technology enterprise specializing in innovative single-use endoscopy solutions, diagnostic equipment, and patient monitoring hardware.
Ambu A/S was founded in Denmark in 1937 by Holger Hesse, originally starting as an enterprise focused on medical device innovation, most notably pioneering the self-inflating manual resuscitator known as the Ambu Bag.
Determining whether Ambu stock represents a favorable purchase at current market levels involves reviewing valuation metrics, revenue expansion forecasts, and consensus analyst research ratings.
Ambu A/S is an authentic and historic Danish multinational medical device enterprise founded, headquartered, and operating primarily in Ballerup, Denmark.
Financial analysts tracking Ambu A/S provide comprehensive twelve-month price predictions and consensus forecasts that fluctuate in response to macroeconomic models, quarterly earnings reports, and international medical device market trends.
Ambu A/S, a Danish medical technology company specializing in single-use endoscopy and diagnostic devices, typically prioritizes reinvesting its operating cash flows into core research and development, global manufacturing expansion, and commercia...
Ambuja Cements distributes regular dividend payments to its eligible shareholders, operating as a well-established dividend-paying industrial entity listed on Indian stock exchanges.
Ambu manufactures its medical devices, diagnostic instruments, and single-use endoscopes across several major international production facilities.
Analyzing the price volatility of AMETEK, Inc.—a leading global manufacturer of electronic instruments and electromechanical devices—reveals a low to moderate volatility profile.
Ambu A/S is a specialized Danish medical technology company headquartered in Ballerup, Denmark, globally recognized as a pioneer in the development, production, and marketing of single-use diagnostic and visualization medical devices.